Silo Pharma (SILO) Receivables - Net (2018 - 2023)

Silo Pharma (SILO) posted Receivables - Net of $69600.0 for Q3 2023, up 1.77% sequentially from $68390.0 in Q2 2023.

Silo Pharma (SILO) Receivables - Net (2018 - 2023) Analysis & Trends

Silo Pharma has reported Receivables - Net for 4 years, with the latest figure at $69600.0 in Q3 2023.

Quarterly Receivables - Net changed N/A year-over-year to $69600.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $69600.0 (changed N/A YoY) and the FY2022 annual result came in at $66010.0, changed N/A from the prior year.
Receivables - Net rose to $69600.0 in Q3 2023 per SILO's latest filing, from $68390.0 in the prior quarter.
Over five years, Receivables - Net peaked at $69600.0 in Q3 2023 and troughed at $23500.0 in Q4 2020.
A 3-year average of $56875.0 and a median of $67200.0 in 2022 frame the typical range for Receivables - Net.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.40 Bn	131.54 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.13 Bn	78.13 Bn	3.93 Bn
3	Argenx Se	65.58 Bn	60.40 Bn	1.37 Bn
4	Moderna	58.23 Bn	53.09 Bn	52.00 Mn
5	BeOne Medicines	42.18 Bn	37.08 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.61 Bn	28.30 Bn	992.69 Mn
7	BioNTech SE	27.97 Bn	9.58 Bn	668.28 Mn
8	Insmed	27.55 Bn	26.39 Bn	358.27 Mn
9	Royalty Pharma	27.31 Bn	26.47 Bn	-
10	Silo Pharma	2.93 Mn	2.93 Mn	-

Download Data